- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03489447
Mortality of Sepsis in Swedish Intensive Care Units 2008-2016
Study Overview
Detailed Description
All adult patients admitted to a general ICU included in the Swedish Intensive Care Registry (a majority of all ICUs in Sweden) between 2008-01-01 and 2016-10-18 are followed for one year and any deaths are registered. Data on illness severity scores, age, sex, admitting hospital and duration of ICU stay are recovered. Data are linked with the inpatient registry of the Swedish Board of Health and Welfare (Socialstyrelsen), and any discharge diagnoses from the last 5 years preceding ICU admission are recovered. These are used to assess chronic comorbidity.
Mortality, adjusted for severity of illness, comorbidity and patient factors, is studied and any changes over time during the inclusion period are assessed.
The data in the Swedish ICU Registry are entered by the treating ICU physicians and include severity of illness (Simplified Acute Physiology Score (SAPS)3), selected chronic comorbidity, sex and date of birth, ICU stay and selected interventions and complications. Relevant International Classification of Diseases (ICD)-10 diagnoses are required and assessment of the occurrence of severe sepsis or septic shock, during the inclusion period defined according to the American College of Chest Physicians/Society of Critical Care Medicine (ACCP/SCCM) (sepsis 2) criteria, is mandatory when entering data.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admission to a Swedish general ICU (excluding specialized cardiothoracic, neurosurgical, pediatric and burns units) between 2008-01-01 and 2016-10-18
- Episode registered in Swedish Intensive Care Registry
Exclusion Criteria:
- Age < 18 years
- Readmission (only first episode during the period included)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Sepsis group
All adult (>= 18 years) patients with a diagnosis of sepsis included in the Swedish ICU Registry between 2008-01-01 and 2016-10-18
|
exposure to ICU treatment with or without diagnosed sepsis
|
|
Non-sepsis group
All adult (>=18 years) patients without a diagnosis of sepsis included in the Swedish ICU Registry between 2008-01-01 and 2016-10-18
|
exposure to ICU treatment with or without diagnosed sepsis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30 day mortality
Time Frame: From the day of ICU admission until death of any cause , whichever came first, assessed up to 30 days.
|
mortality within 30 days after admission to ICU
|
From the day of ICU admission until death of any cause , whichever came first, assessed up to 30 days.
|
|
90 day mortality
Time Frame: From the day of ICU admission until death of any cause, whichever came first, assessed up to day 90.
|
mortality within 90 days after admission to ICU
|
From the day of ICU admission until death of any cause, whichever came first, assessed up to day 90.
|
|
365 day mortality
Time Frame: From the day of ICU admission until death of any cause , whichever came first, assessed up to day 365.
|
mortality within 365 days after admission to ICU
|
From the day of ICU admission until death of any cause , whichever came first, assessed up to day 365.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hospital mortality
Time Frame: From the day of ICU admission until death of any cause or day of hospital discharge, whichever came first, assessed up to day 365.
|
mortality before discharge from hospital after admission to ICU
|
From the day of ICU admission until death of any cause or day of hospital discharge, whichever came first, assessed up to day 365.
|
|
ICU length of stay
Time Frame: From the day of ICU admission until death of any cause or day of ICU discharge, whichever came first, assessed up to day 365.
|
From the day of ICU admission until death of any cause or day of ICU discharge, whichever came first, assessed up to day 365.
|
|
|
hospital length of stay
Time Frame: From the day of ICU admission until death of any cause or day of hospital discharge , whichever came first, assessed up to day 365.
|
From the day of ICU admission until death of any cause or day of hospital discharge , whichever came first, assessed up to day 365.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015/519
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.